CLARINEX-D 12 HOUR Rx
Generic Name and Formulations:
Desloratadine 2.5mg, pseudoephedrine sulfate 120mg; ext-rel tabs.
Merck & Co., Inc.
Indications for CLARINEX-D 12 HOUR:
Seasonal allergic rhinitis with nasal congestion.
Swallow whole. 1 tab twice daily.
Narrow-angle glaucoma. Urinary retention. Severe hypertension or coronary artery disease. During or within 14 days of MAOIs.
Cardiovascular disorders. Diabetes. Hyperthyroidism. Prostatic hypertrophy. Increased intraocular pressure. Renal or hepatic impairment: avoid. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
See Contraindications. Pseudoephedrine: Antagonizes beta-adrenergic blocking agents, methyldopa, and reserpine. Increased ectopic pacemaker activity with digitalis.
Antihistamine + sympathomimetic.
Dry mouth, headache, insomnia, fatigue, pharyngitis, somnolence, nausea, dizziness, nervousness, psychomotor hyperactivity, anorexia; hypersensitivity reactions (discontinue if occurs).
Endocrinology Advisor Articles
- Clinicians May Be Overtreating Older Patients With Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Prediabetes a Useful Indicator for Cardiovascular and Renal Risks
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Gut Microbiota Profiles in Prediabetes
- Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B
- Young Adults With Type 1 Diabetes Show Muscle Metabolic Deficiencies
- Social Support of Autonomy Tied to Better Glycemic Control in Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation